am 251 and hu 210
am 251 has been researched along with hu 210 in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Drmota, T; Elebring, T; Greasley, PJ; Hermansson, NO; Hjorth, S; Larsson, N; Leonova, J; Nilsson, K; Ryberg, E; Sjögren, S | 1 |
Adams, Y; Ahenkorah, S; Laitinen, JT; Laitinen, T; Navia-Paldanius, D; Nevalainen, TJ; Parkkari, T; Patel, JZ; Savinainen, JR; Staszewski, M; Vaara, M; Walczyński, K | 1 |
Kaczor, AA; Laitinen, JT; Laitinen, T; Navia-Paldanius, D; Nevalainen, TJ; Parkkari, T; Patel, JZ; Savinainen, JR; van Bruchem, J | 1 |
Other Studies
3 other study(ies) available for am 251 and hu 210
Article | Year |
---|---|
The orphan receptor GPR55 is a novel cannabinoid receptor.
Topics: Amino Acid Sequence; Animals; Arachidonic Acids; Binding Sites; Binding, Competitive; Cannabidiol; Cannabinoids; Cell Line; Cloning, Molecular; Cyclohexanols; Down-Regulation; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Mice; Molecular Sequence Data; Organ Specificity; Polymerase Chain Reaction; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Structure-Activity Relationship | 2007 |
Loratadine analogues as MAGL inhibitors.
Topics: Amidohydrolases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Loratadine; Models, Molecular; Molecular Structure; Monoacylglycerol Lipases; Recombinant Proteins; Structure-Activity Relationship | 2015 |
Revisiting 1,3,4-Oxadiazol-2-ones: Utilization in the Development of ABHD6 Inhibitors.
Topics: Animals; Binding Sites; Catalytic Domain; Enzyme Inhibitors; Mice; Molecular Docking Simulation; Monoacylglycerol Lipases; Oxadiazoles; Protein Binding; Receptors, Cannabinoid; Serine Proteases; Structure-Activity Relationship | 2015 |